- Home
- GOVX vs IVDA Comparison
GOVX vs IVDA Comparison
Compare GOVX & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | IVDA |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GOVX | IVDA |
|---|---|---|
| Price | $1.87 | $0.30 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $200.00 | N/A |
| AVG Volume (30 Days) | 129.8K | ★ 6.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $340.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.22 |
| 52 Week High | $4.40 | $3.55 |
Technical Indicators
Market Signals| Indicator | GOVX | IVDA |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 34.56 |
| Support Level | $0.55 | $0.27 |
| Resistance Level | $4.40 | $1.12 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 88.89 | 28.05 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).